Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.87) per share. This is a 35.94 percent decrease over losses of $(0.64) per share from the same period last year. The company reported $644.00 thousand in sales this quarter. This is a 92.21 percent decrease over sales of $8.27 million the same period last year.
Craig-Hallum Upgrades Model N to Buy, Raises Price Target to $41
Craig-Hallum analyst Chad Bennett upgrades Model N (NYSE:MODN) from Hold to Buy and raises the price target from $40 to $41.
